Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Terminated
×
ublituximab
×
Clear all
Filters
3
NCT03801525
2024-04-19
ULTRA-V
TG Therapeutics, Inc.
Phase 2/3
Terminated
277 enrolled
19 charts
NCT02793583
2022-07-21
UNITY-NHL
TG Therapeutics, Inc.
Phase 2/3
Terminated
710 enrolled
1 FDA